We have presented a self-cross-link strategy to fabricate HSA nanoparticles using a desolvation method. The nanoparticles were stabilized by intermolecular disulfide bonds while still dissolvable in reducing media. The fabrication process does not involve any toxic chemicals and hence the nanoparticles may be useful as a drug carrier.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: